open access
Primary antiphospholipid syndrome in a male with myocardial infarction with non-obstructive coronary arteries and a history of stroke
Affiliations- Department of Coronary Disease and Heart Failure, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland
- John Paul II Hospital, Kraków, Poland
- Department of Radiology and Diagnostic Imaging, John Paul II Hospital, Kraków, Poland
open access
Abstract
Abstract
Supp./Additional Files (6)
About this articleTitle
Primary antiphospholipid syndrome in a male with myocardial infarction with non-obstructive coronary arteries and a history of stroke
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Clinical vignette
Pages
195-197
Published online
2022-12-20
Page views
379
Article views/downloads
91
DOI
10.33963/KP.a2022.0295
Pubmed
Bibliographic record
Kardiol Pol 2023;81(2):195-197.
Authors
Paweł Rostoff
Dominika Drwiła-Stec
Krzysztof Karwat
Małgorzata Urbańczyk-Zawadzka
Jadwiga Nessler
Ewa Konduracka
References (5)- Calcaterra I, Tufano A, Lupoli R, et al. Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat? Pol Arch Intern Med. 2021; 131(2): 161–170.
- Lóczi L, Kappelmayer J, Tarr T, et al. Antiphospholipid syndrome and the risk of myocardial infarction: current evidence and uncertainties. Kardiol Pol. 2020; 78(1): 6–14.
- Žigon P. Do antiphospholipid antibodies enhance thromboembolic risk in patients with cancer? Pol Arch Intern Med. 2020; 130(12): 1026–1028.
- Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002; 46(4): 1019–1027.
- Zasada W, Bobrowska B, Plens K, et al. Acute myocardial infarction in young patients. Kardiol Pol. 2021; 79(10): 1093–1098.
